The Science of Modern Breast Implants: A Qualitative and Quantitative Comparison of Silicone Breast Devices

BACKGROUND: Breast implants remain the cornerstone of aesthetic and reconstructive breast surgery, yet surgeon device selection is frequently driven by manufacturer marketing, social media, and brand loyalty rather than objective scientific data. OBJECTIVES: To provide a comprehensive, side-by-side qualitative and quantitative comparison of current-generation silicone gel breast implants from the four major United States manufacturers, characterizing each device's gel, shell, and gel-shell interface properties. METHODS: Two unopened, current-generation implants were obtained from each of Allergan (Inspira Responsive, Inspira SoftTouch), Mentor (MemoryGel BOOST, MemoryGel Xtra), Motiva (Ergonomix, Round), and Sientra (106/HSC, 107/HSC+). Eight assessment methods were applied: still-photo tilt-table analysis, time-in-motion video analysis, gel-shell pinch-roll testing, BTC 2000 biomechanical gel evaluation, tensiometer gel-shell peel testing, in vivo high-resolution ultrasound imaging, blinded patient tactile assessment, and matrix usability scoring. RESULTS: Mentor MemoryGel BOOST demonstrated the most form-stable gel across all five BTC 2000 parameters, the longest pinch-roll endpoint, and the longest tensiometer peel time with significant retained gel, indicating the strongest gel-shell interaction. Despite this form stability, BOOST was the third-highest-rated implant on blinded patient tactile assessment, with MemoryGel Xtra ranked first. Sientra 106 was consistently the least form-stable. Allergan implants demonstrated the highest ultrasound shell visualization clarity. Allergan also achieved the highest matrix usability score, reflecting broad profile diversity across aesthetic and reconstructive applications. CONCLUSIONS: Current silicone gel breast implants demonstrate measurable, manufacturer-specific differences in gel behavior, shell properties, gel-shell interaction, sonographic appearance, and clinical applicability. These findings support a paradigm shift toward science-driven implant selection and provide objective data to guide surgeon decision-making.